Nielsen Camilla Littau, Zachariassen Gitte, Holm Kristina Garne
Hans Christian Andersen Children's Hospital, Odense University Hospital.
OPEN, Open Patient data Explorative Network, Odense University Hospital.
Dan Med J. 2022 Apr 7;69(5):A05210463.
Central line (CL)-associated bloodstream infection (CLABSI) is one of the most common and yet preventable hospital-acquired infections in infants admitted to neonatal intensive care units (NICUs) and is associated with significant morbidity. The objectives of this retrospective study were to 1) determine the incidence rates of CLABSI in infants admitted to a level lll NICU and to 2) identify independent CLABSI risk factors in high-risk infants.
Data were collected from patient medical records, and incidence rates were calculated per 1,000 CL days and per 1,000 patient (PT) days. Univariate analyses were performed to identify potential risk factors associated with CLABSI, and those with a p-value ≤ 0.05 were assessed in multivariate analyses.
The cohort represented 382 infants in whom 512 CLs were inserted. The CLABSI incidence rates per 1,000 CL days and per 1,000 PT days were 13.41 and 3.18, respectively. The only independent risk factor for CLABSI was prolonged CL dwell-time for the groups of umbilical catheters (adjusted odds ratio (aOR) = 1.42 per day (95% confidence interval (CI): 1.15-1.75)) and central venous catheters (aOR = 1.04 per day (95% CI: 1.01-1.07)).
Compared with other high-income countries, our overall incidence rate seems high. Since units of measurement and the definition used for CLABSI vary between studies, it is important to keep this in mind when comparing findings. Future research should focus on preventative measures in relation to CLs.
none Trial registration. not relevant.
中心静脉导管(CL)相关血流感染(CLABSI)是入住新生儿重症监护病房(NICU)的婴儿中最常见但可预防的医院获得性感染之一,且与显著的发病率相关。这项回顾性研究的目的是:1)确定入住三级NICU的婴儿中CLABSI的发病率;2)识别高危婴儿中独立的CLABSI危险因素。
从患者病历中收集数据,并计算每1000个CL日和每1000个患者日的发病率。进行单因素分析以识别与CLABSI相关的潜在危险因素,并在多因素分析中评估p值≤0.05的因素。
该队列包括382名插入了512根CL的婴儿。每1000个CL日和每1000个患者日的CLABSI发病率分别为13.41和3.18。CLABSI的唯一独立危险因素是脐静脉导管组和中心静脉导管组的CL留置时间延长(调整优势比(aOR):脐静脉导管组每日为1.42(95%置信区间(CI):1.15 - 1.75),中心静脉导管组每日为1.04(95%CI:1.01 - 1.07))。
与其他高收入国家相比,我们的总体发病率似乎较高。由于不同研究中CLABSI的测量单位和定义有所不同,在比较研究结果时牢记这一点很重要。未来的研究应关注与CL相关的预防措施。
无。试验注册:不相关。